Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. VSEE
VSEE logo

VSEE Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.280
Open
0.280
VWAP
0.27
Vol
273.90K
Mkt Cap
12.50M
Low
0.264
Amount
75.24K
EV/EBITDA(TTM)
--
Total Shares
43.24M
EV
22.61M
EV/OCF(TTM)
--
P/S(TTM)
0.30
VSee Health, Inc. is a telehealth technology and services company delivering virtual care solutions through its application programming interface (API)-driven platform. The platform integrates secure video streaming with medical device data, electronic medical records, and other sensitive health information, offering customizable and white-labeled solutions for healthcare providers, employers, and hospital systems. The Company operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions.
Show More

Events Timeline

(ET)
2026-02-05
09:00:00
VSEE Health Partners with GoMyRx for Strategic Managed Services
select
2026-01-29 (ET)
2026-01-29
08:30:00
VSee Health Partners with DocBox for Next-Gen Virtual ICU
select
2026-01-12 (ET)
2026-01-12
09:40:00
VSee Health Launches AI-Enhanced Rural Health Transformation Solution
select
2025-12-29 (ET)
2025-12-29
16:50:00
VSee Health files to sell 3M shares of common stock for holders
select
2025-11-26 (ET)
2025-11-26
08:31:30
VSee Health sets price for 9.84 million shares at 61 cents in private placement
select
2025-11-25 (ET)
2025-11-25
08:25:24
VSee Health Reports Advancements in Contract Fulfillment via iDoc
select
2025-11-17 (ET)
2025-11-17
09:11:19
VSee Health announces Q3 earnings per share of 2 cents compared to a loss of $3.58 in the same quarter last year.
select
2025-11-11 (ET)
2025-11-11
08:28:58
VSee Health Incorporates Cutting-Edge Robotic Support in Intensive Care Units
select

News

seekingalpha
7.5
01-29seekingalpha
VSee Health Partners with DocBox for AI-Driven ICU Platform
  • Strategic Partnership: VSee Health has entered a strategic partnership with DocBox to develop an augmented intelligence platform for virtual ICUs, enhancing remote critical care capabilities for hospitals worldwide.
  • Data Integration: DocBox's real-time, vendor-agnostic bedside data infrastructure will be integrated into VSee's telehealth platform, embedding augmented intelligence directly into live ICU clinical workflows to improve clinical decision-making efficiency.
  • Clinical Intelligence: The joint platform will convert continuous bedside device data into actionable clinical intelligence, supporting scalable remote critical care delivery and optimizing hospital operational efficiency.
  • Data Ownership: The platform allows hospitals to retain ownership of their clinical data while enabling automated billing capture and deployment of AI tools, further solidifying VSee's market position in AI-enabled virtual healthcare.
Benzinga
2.0
2025-12-01Benzinga
Vision Marine Technologies Stock Rises Over 10%; Check Out 20 Stocks Making Moves in Premarket Trading
  • Vision Marine Technologies Performance: Vision Marine Technologies Inc. shares rose 10.5% to $1.36 in pre-market trading after announcing strong financial results for the fiscal year ending August 31, 2025, and highlighting strategic expansion following the acquisition of Nautical Ventures, which generated $12.8 million in revenue.

  • Other Gainers in Pre-Market Trading: Several stocks saw significant gains in pre-market trading, including WEBUY Global Ltd. (+62.1%), Direct Digital Holdings, Inc. (+60.6%), and INVO Fertility, Inc. (+24.7%), with various companies announcing acquisitions or strategic plans.

  • Notable Losers in Pre-Market Trading: SMX (Security Matters) PLC experienced a sharp decline of 24.6% after a previous surge, while Springview Holdings Ltd. fell 20.7% following a reverse share split announcement.

  • Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with some companies like New Fortress Energy Inc. and Canadian Solar Inc. also reporting notable increases.

Benzinga
9.5
2025-10-29Benzinga
Teradyne Shares Surge Over 20%; Check Out 20 Stocks Making Moves in Premarket Trading
  • Teradyne's Strong Performance: Teradyne Inc. shares surged 20.7% in pre-market trading after reporting third-quarter earnings of 85 cents per share, exceeding analyst expectations of 79 cents, along with sales of $769.210 million, surpassing the $743.776 million estimate.

  • Notable Gainers: Several stocks saw significant pre-market gains, including Profusa Inc. (+72.8%), Founder Group Ltd (+59.4%), and Vsee Health Inc. (+44.3%), driven by positive developments such as manufacturing capacity increases and regulatory approvals.

  • Major Losers: Stride Inc. experienced a sharp decline of 36.4% after providing disappointing sales guidance, while Varonis Systems Inc. and Akebia Therapeutics Inc. also fell significantly due to lower-than-expected revenue and trial design issues, respectively.

  • Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with notable movements in both directions, reflecting investor reactions to earnings reports and company announcements.

Benzinga
2.0
2025-10-29Benzinga
What Caused VSee Health's Stock to Surge More Than 45% Overnight?
  • Stock Surge: VSee Health Inc. saw a significant increase in its stock price, rising 45.28% to $1.54 in after-hours trading, following a 71.66% increase during regular trading hours.

  • Federal Authorization: The company received FedRAMP High authorization from the Department of Health and Human Services, enabling federal agencies to utilize its telehealth platform for secure patient care.

  • Financial Performance: VSee reported a revenue of $3.4 million for the second quarter, marking a 98% increase year-over-year, with a gross profit margin improvement to 47%.

  • Market Trends: Despite a year-to-date decline of 22.06%, VSee's stock has surged 68.25% over the past month, although it has a negative price trend across all time frames according to Benzinga Edge Stock Rankings.

Benzinga
4.5
2025-10-28Benzinga
Crude Oil Drops More Than 2%; PayPal Stock Rises Sharply
  • U.S. Stock Market Performance: U.S. stocks saw gains, with the Dow up 0.39%, Nasdaq rising 0.42%, and S&P 500 increasing by 0.07%. Information technology shares led the rise, while real estate stocks fell by 1.6%.

  • PayPal's Strong Performance: PayPal's stock surged 12% after announcing a collaboration with OpenAI, reporting a 7% year-over-year revenue growth to $8.42 billion, and exceeding earnings expectations.

  • Notable Stock Movements: Vsee Health's shares skyrocketed 221% after receiving operational authority, while Arcutis Biotherapeutics and Wayfair also saw significant gains. Conversely, Co-Diagnostics and Alexandria Real Estate Equities experienced substantial declines.

  • Global Market Trends: European shares were mixed, with the STOXX 600 down 0.32%, while Asian markets closed lower. In economic news, U.S. house prices rose 0.4% month-over-month in August, and private businesses added an average of 14,250 jobs weekly.

Benzinga
9.5
2025-10-28Benzinga
Dow Rises More Than 100 Points as UPS Reports Strong Q3 Earnings
  • U.S. Stock Market Performance: U.S. stocks saw gains with the Dow Jones up over 100 points, while the NASDAQ rose 0.45%. The S&P 500 experienced a slight decline of 0.01%.

  • Sector Movements: Information technology stocks increased by 0.8%, whereas real estate stocks fell by 2.1%.

  • UPS Financial Results: United Parcel Service (UPS) reported better-than-expected third-quarter earnings of $1.74 per share and projected fourth-quarter sales above estimates.

  • Global Market Trends: European shares mostly declined, with the eurozone's STOXX 600 down 0.3%, and Asian markets also closed lower, reflecting a broader trend of market downturns.

Valuation Metrics

The current forward P/E ratio for Vsee Health Inc (VSEE.O) is -1.17, compared to its 5-year average forward P/E of -0.80. For a more detailed relative valuation and DCF analysis to assess Vsee Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-0.80
Current PE
-1.17
Overvalued PE
0.52
Undervalued PE
-2.12

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.98
Current EV/EBITDA
-6.86
Overvalued EV/EBITDA
1.10
Undervalued EV/EBITDA
-5.07

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.32
Current PS
1.00
Overvalued PS
0.83
Undervalued PS
-0.19

Financials

AI Analysis
Annual
Quarterly

Whales Holding VSEE

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Vsee Health Inc (VSEE) stock price today?

The current price of VSEE is 0.28 USD — it has decreased -3.11

What is Vsee Health Inc (VSEE)'s business?

VSee Health, Inc. is a telehealth technology and services company delivering virtual care solutions through its application programming interface (API)-driven platform. The platform integrates secure video streaming with medical device data, electronic medical records, and other sensitive health information, offering customizable and white-labeled solutions for healthcare providers, employers, and hospital systems. The Company operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions.

What is the price predicton of VSEE Stock?

Wall Street analysts forecast VSEE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for VSEE is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Vsee Health Inc (VSEE)'s revenue for the last quarter?

Vsee Health Inc revenue for the last quarter amounts to 3.98M USD, increased 18.67

What is Vsee Health Inc (VSEE)'s earnings per share (EPS) for the last quarter?

Vsee Health Inc. EPS for the last quarter amounts to -0.02 USD, decreased -99.44

How many employees does Vsee Health Inc (VSEE). have?

Vsee Health Inc (VSEE) has 154 emplpoyees as of March 12 2026.

What is Vsee Health Inc (VSEE) market cap?

Today VSEE has the market capitalization of 12.50M USD.